CPT1A and metabolic syndrome: Decreased methylation status at the CPT1A locus has been associated with lipid profile (22, 33), insulin resistance (25), and metabolic syndrome (34), as well as obesity (35) in GOLDN, and some of these findings were replicated in other populations (35).